Elevated NCAM1 serum levels have been previously associated with various forms of inflammatory neuropathies and with CMT1A [75] as well as with Alzheimer’s disease [76], indicating that it may be a relatively broad marker of CNS and PNS neurodegeneration. This evidence concerns the gene NCAM1 and Alzheimer disease.